SHREE GANESH BIOTECH (INDIA) LTD - Board Meeting Outcome for Revised Un-Audited Financial Result Quarter Ending 30Th June, 2022 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015E

Rediff Moneywiz

Hi Guest
Feedback

Shree Ganesh Biotech (India) Ltd - Board Meeting Outcome for Revised Un-Audited Financial Result Quarter Ending 30Th June, 2022 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015E

Download	< Back
25 Jul 2022
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday July 25, 2022 at the Registered Office of the Company and transacted the following business. Note: Due to typo error and erratum find herewith revised Un-Audited Financial Result quarter ending 30th June, 2022 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015.
View all announcements for Shree Ganesh Biotech (India) Ltd	Source: BSE India

ALL MONEYWIZ PAGES